The Allegro Connect bulk fill system from Cytiva has been designed to help you reduce non-recoverable product loss by up to ...

RxCell has received a US patent for an iPSC-based cell therapy approach, a method of generating multiple cellular therapy ...

The biotech has secured $65m in a Series A funding round led by Cormorant Asset Management and other investors.

Emmanuelle Cameau is strategic technology partnership leader at Cytiva. Read our interview to discover how losing her beloved ...

Beate Mueller-Tiemann is chief technology officer at Cytiva. With a passion for science and an ‘eternal technology optimist’, ...

The choice of scaling strategy—“up,” “out,” or “down”—depends on a biomanufacturer’s business strategy and product demand ...

The cell-based assays market is expected to grow from USD 17.3 billion in 2024 to USD 24.3 billion by 2029, reflecting a ...

In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion ...

Brandon Couillard, an analyst from Wells Fargo, maintained the Hold rating on Danaher (DHR – Research Report). The associated price ...